• Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 8.5b: Stent Thrombosis: Incidence, Timing, Outcome, Optimizing Pharmacology

    Martin B. Leon, MD — Columbia University Medical Center, Cardiovascular Research Foundation

    Duration:1 hour

    Faculty Disclosure

    Nothing to Disclose

    Learning Objectives

    • Describe sirolimus-eluting stent (SES) components and drug actions
    • Explain the angiographic and clinical results of randomized trials comparing SES and bare metal stents (BMS)
    • Review the effects of SES in complex lesion subsets
    • Discuss the frequency of early and late stent thrombosis after SES implantation